Aurobindo Pharma Q3 PAT Seen up 13.8 Percent YoY to Rs. 669.1 Crore

ICICI Direct has come out with its third quarter (October-December’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Aurobindo Pharma to report net profit at Rs. 669.1 crore up 13.8 percent year-on-year (up 4.8 percent quarter-on-quarter). Net Sales are expected to increase by 15.8 percent Y-o-Y (up 5.7 percent Q-o-Q) to Rs. 5022.3 crore, according to ICICI Direct. Earnings before interest, tax, depreciation and amortization (EBITDA) are likely to rise by 2.9 percent Y-o-Y (up 7 percent Q-o-Q) to Rs. 1055.5 crore. – Money Control